Mutant mammals with normal lifespan: an underappreciated resourse
A.D.N.J. de Grey
Department of Genetics,
University of Cambridge,
Downing Street,
Cambridge CB2 3EH,
UK
Biogerontology proceeds largely by designing interventions to alter the
life expectancy, or sometimes the maximum lifespan, of an experimental
population. Interventions designed to extend an organism's lifespan
are often claimed to be far more informative than ones designed to
shorten it, because shortening lifespan can be done in innumerable ways
that do not necessarily have anything to do with what limited the
controls' lifespan, whereas to extend lifespan one must modulate all
the organism's life-limiting processes. I suggest that this overlooks
a critical point. Our goal is to test hypotheses concerning which
mechanisms do and do not greatly influence lifespan. An intervention
that extends lifespan does not generally do this, because putative
markers of lifespan-limiting processes (PMLPs) that are postponed may
be causal in determining lifespan or may be mere bystanders, while
ones that are not postponed may be unimportant for lifespan or may be
important but better tolerated because of the intervention. Moreover,
interventions designed to extend lifespan but which fail to do so also
tell us nothing, because PMLPs that they postpone are not shown to be
irrelevant (only to be not the only ones that are relevant), while ones
that are not postponed are again neither supported nor challenged (they
could either matter or not for lifespan). When the intervention is
designed to shorten lifespan, on the other hand, information can be
gained that truly falsifies hypotheses. True, when lifespan is indeed
shortened we learn little, since the organism may have been killed by
something irrelevant to controls: thus, no PMLPs are falsified. But if
lifespan is unaffected by the intervention, the situation is totally
different: any PMLP that is accelerated is unambiguously eliminated as
being relevant to the determination of lifespan in that organism. I
will discuss the many mammalian examples of this "failed shortening of
lifespan" that are now available and a number of tests of prominent
hypotheses that they make possible.
Key words:
mammals, lifespan, interventions, falsification
Problems or questions regarding this site should be directed to
webmaster@americanaging.org